Cargando…
The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
Background: The metastatic site seems to represent a malignancy with a different biological characteristic and is an important prognostic factor in metastatic pancreatic ductal adenocarcinoma (mPDAC). Palliative radiotherapy is a therapeutic option, and usually used for pain management in the treatm...
Autores principales: | Xu, Biaoxiang, Zhou, Yuan, Pei, Qian, Tan, Fengbo, Zhao, Lilan, Güngör, Cenap, Wang, Dan, Li, Yuqiang, Liu, Wenxue, Zhou, Zhongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771529/ https://www.ncbi.nlm.nih.gov/pubmed/35069888 http://dx.doi.org/10.7150/jca.64800 |
Ejemplares similares
-
The survival impact of radiotherapy on synchronous metastatic rectal cancer: metastatic site can serve for radiotherapy-decision
por: Zhou, Yuan, et al.
Publicado: (2022) -
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
por: Wang, Dan, et al.
Publicado: (2020) -
The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age
por: Li, Yuqiang, et al.
Publicado: (2021) -
Establishment and Verification of Synchronous Metastatic Nomogram for Gastrointestinal Stromal Tumors (GISTs): A Population-Based Analysis
por: Li, Yuqiang, et al.
Publicado: (2020) -
A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy
por: Li, Yuqiang, et al.
Publicado: (2021)